New Japanese RCT Landmark Results: Exclusive Human Milk Diet Drives Superior Growth in Premature Infants Without Increased Safety Risks

Skip to main content

Resources & Evidence Contact us

Healthcare Professionals
- Clinical
- Financial
  - Cost-benefit analysis
Parents
Donors
Quality & Innovation
- Quality & innovation overview
- Human milk safety
Products
About Us
- Get to Know Us
- Connect With Us
  - News
  - Media
  - Conferences
  - Contact us

Supplemental Product Information: Prolact+4 H2MF (10ml)

Prolacta > Resource Library > Supplemental Product Information: Prolact+4 H2MF (10ml)

Topic(s):

Related resources

CE Webinar: One baby to drug approval: Moving toward equity with human milk feeding in VLBW infants

Webinar

Webinar: Human milk as therapy: Optimizing recovery and enteral autonomy for infants with gastroschisis

Webinar

Webinar: Human vs bovine milk fortifiers: Has the quest for evidence just begun?

Webinar

We have updated our Privacy Notice and Cookie Policy, effective February 25, 2026. In accordance with these policies, when you visit our websites, we may collect data about you using cookies and similar third party tracking technologies ("Cookies"). Cookies may be necessary for the basic functionality of the website, as well as other purposes such as targeted advertising and analytics. Your continued use of the website constitutes your consent to Cookies. For more information on our privacy practices, including how to manage certain types of Cookies, please visit Privacy Notice and Cookie Policy.

Do not sell or share my Personal Information

General inquiries

info@prolacta.com

Policy related inquiries

privacy@prolacta.com

Copyright © 2026 Prolacta. All Rights Reserved.

Terms of Use Privacy Notice CA Privacy Statement Cookie policy Regulatory Information Consumer Health Data Privacy Notice